How the Microbiome Shapes HPV Infection and Gynecological Cancer Risk
A new review synthesizes evidence that gut and vaginal microbiota dysbiosis promotes persistent HPV infection and the development of cervical, ...
A new review synthesizes evidence that gut and vaginal microbiota dysbiosis promotes persistent HPV infection and the development of cervical, ...
A new preclinical study shows that the β-catenin/CBP inhibitor ICG-001 selectively kills endometrial cancer cells carrying both PIK3CA and CTNNB1 ...
A new Viewpoint in eClinicalMedicine argues that immune checkpoint inhibitors have not yet proven they can replace pelvic radiotherapy in ...
New research reveals that the RNA modification reader ALYREF drives endometrial cancer progression by stabilizing XRCC6 mRNA and activating Wnt/β-catenin ...
Japanese researchers found that the metabolic enzyme ME1 predicts poor outcomes in endometrioid endometrial carcinoma and that inhibiting it restores ...
A new review maps how the gut hormones behind blockbuster weight-loss drugs may also influence PCOS, endometriosis and gynaecological cancers.
A phase 1b/2 trial found that the oral CBP–β-catenin inhibitor E7386 combined with lenvatinib produced durable responses in advanced endometrial ...
New research shows that fibrinogen-like protein 1 is overexpressed in endometrial adenocarcinoma and drives tumor growth, migration and invasion by ...
A new editorial in Cancer Causes & Control argues that the most powerful tools against breast, ovarian, cervical, and endometrial ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine